Study
Bryan Johnson announces a new Blueprint creatine batch
NEW PRODUCT DROP / CONTROVERSY: Johnson says a new batch of Blueprint creatine came off the line after a reported $630,000 shipment theft; no clinical result or product test is reported.
On 18 September 2026, Bryan Johnson posted that $630,000 of “elite Blueprint creatine” had been stolen earlier in the year after a driver used a fake ID to take the delivery truck. He said the company had come close to finding the person and that a new batch had just come off the production line. The post is a supply and product-availability update, not a creatine experiment. It gives no batch number, certificate of analysis, manufacturing test, quantity available, release date, price change, adverse-event information or evidence that the product differs from earlier batches. The theft allegation is Johnson’s own account; this record does not add unverified details about a suspect. A new production batch does not show that Blueprint creatine improves strength, cognition, healthspan or longevity. The post also does not report whether the product is available to consumers or whether the new batch underwent independent testing. It is included because the task tracks product drops and public protocol-adjacent updates. The evidence boundary is simple: a new batch was announced, but no clinical or comparative product result was supplied.
A new batch came off the line; no scientific conclusion or clinical outcome is reported.
No relevant critic or new human RCT/meta-analysis tested this product update. The announcement does not support a creatine evidence-grade change.
From this page back to the goal it moves.
Cited by
2 encyclopedia entries reference this study.